Discovery of INCB098377: a potent inhibitor of phosphoinositide 3-kinase gamma (PI3Kγ)

被引：0
|
作者：
Arias, Diana A.
Douglass, Stephen
Truong, Lisa
Wang, Qian
Wang, Kathy H.
Yang, Gengjie
Hansbury, Michael
O'Connor, Sybil
Bowman, Kevin
Collins, Robert
Stubbs, Matthew
Hall, Leslie
Stevens, Christina
Maddage, Christopher
Douty, Brent
Covington, Maryanne
Leffet, Lynn
Yue, Eddy
Combs, Andrew
Kim, Sunkyu
Shin, Niu
Koblish, Holly
Hess, Rodrigo
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5162
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5162
引用
收藏
页数：3
相关论文
共 50 条
  • [31] ALPELISIB Phosphatidylinositol 3-kinase alpha (PI3Kα) inhibitor Oncolytic
    Heymann, M-F.
    Renema, N.
    Heymann, D.
    DRUGS OF THE FUTURE, 2015, 40 (04) : 213 - 223
  • [32] In vitro and in vivo pharmacological properties of the potent phosphatidylinositol 3-kinase (PI3K) family inhibitor PI103
    Raynaud, F.
    Eccles, S.
    Clarke, P.
    Hayes, A.
    Di Stefano, F.
    Ahmad, Z.
    Guillard, S.
    Patel, S.
    Workman, P.
    EJC SUPPLEMENTS, 2006, 4 (12): : 172 - 172
  • [33] Phosphoinositide 3-Kinase (PI3K) Inhibitors and Breast Cancer: An Overview of Current Achievements
    Bertucci, Alexandre
    Bertucci, Francois
    Goncalves, Anthony
    CANCERS, 2023, 15 (05)
  • [34] A bibliometric analysis of highly cited Phosphoinositide 3-Kinase (PI3K) research papers
    Ho, Yuh-Shan
    Hartley, James
    COLLNET JOURNAL OF SCIENTOMETRICS AND INFORMATION MANAGEMENT, 2020, 14 (01) : 37 - 54
  • [35] Human target validation of phosphoinositide 3-kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor
    Nylander, S.
    Kull, B.
    Bjorkman, J. A.
    Ulvinge, J. C.
    Oakes, N.
    Emanuelsson, B. M.
    Andersson, M.
    Skarby, T.
    Inghardt, T.
    Fjellstrom, O.
    Gustafsson, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (10) : 2127 - 2136
  • [36] Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors
    D'Angelo, Noel D.
    Kim, Tae-Seong
    Andrews, Kristin
    Booker, Shon K.
    Caenepeel, Sean
    Chen, Kui
    D'Amico, Derin
    Freeman, Dan
    Jiang, Jian
    Liu, Longbin
    McCarter, John D.
    Miguel, Tisha San
    Mullady, Erin L.
    Schrag, Michael
    Subramanian, Raju
    Tang, Jin
    Wahl, Robert C.
    Wang, Ling
    Whittington, Douglas A.
    Wu, Tian
    Xi, Ning
    Xu, Yang
    Yakowec, Peter
    Yang, Kevin
    Zalameda, Leeanne P.
    Zhang, Nancy
    Hughes, Paul
    Norman, Mark H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (06) : 1789 - 1811
  • [37] Lead optimization of a dihydropyrrolopyrimidine inhibitor against phosphoinositide 3-kinase (PI3K) to improve the phenol glucuronic acid conjugation
    Kawada, Hatsuo
    Ebiike, Hirosato
    Tsukazaki, Masao
    Nakamura, Mitsuaki
    Morikami, Kenji
    Yoshinari, Kiyoshi
    Yoshida, Miyuki
    Ogawa, Kotaro
    Shimma, Nobuo
    Tsukuda, Takuo
    Ohwada, Jun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (03) : 673 - 678
  • [38] Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis
    Taha, Mutasem O.
    Al-Sha'er, Mahmoud A.
    Khanfar, Mohammad A.
    Al-Nadaf, Afaf H.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 84 : 454 - 465
  • [39] Activation loop sequences confer substrate specificity to phosphoinositide 3-kinase α (PI3Kα) -: Functions of lipid kinase-deficient PI3Kα in signaling
    Pirola, L
    Zvelebil, MJ
    Bulgarelli-Leva, G
    Van Obberghen, E
    Waterfield, MD
    Wymann, MP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) : 21544 - 21554
  • [40] SONOLISIB Pan-Phosphatidylinositol 3-Kinase (PI3K) Inhibitor Oncolytic
    Azad, Arun
    Chi, Kim N.
    DRUGS OF THE FUTURE, 2013, 38 (05) : 299 - 307
12345